
Ceroxitum CV 500mg/125mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Ceroxitum CV 500mg/125mg Tablet
Combiflox 500mg/125mg tablets combat diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. This prescription medication should be taken precisely as directed. It may be consumed with or without food, but consistent timing optimizes effectiveness. Exceeding the prescribed dosage can be detrimental. Missed doses should be taken promptly upon recall. Complete the entire treatment course, even with symptom improvement; premature cessation may reduce efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; consult a physician if these worsen. Seek immediate medical attention for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration contribute to faster recovery. Your doctor might order tests to monitor the drug's effects.
Primary Ingredients of Ceroxitum CV 500mg/125mg Tablet
No information provided. A rephrased version cannot be created.
Uses of Ceroxitum CV 500mg/125mg Tablet
Combating Bacterial Infections
Major Benefits of Ceroxitum CV 500mg/125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ceroxitum CV 500mg/125mg Tablet whole; do not alter its form. While food isn't required, consistent daily timing is recommended.
Common Side effects of Ceroxitum CV 500mg/125mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Ceroxitum CV 500mg/125mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Ceroxitum CV 500mg/125mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Ceroxitum CV 500mg/125mg Tablet works:
Each Ceroxitum CV 500mg/125mg tablet unites Cefuroxime, an antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. Cefuroxime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Clavulanic Acid counteracts bacterial enzymes that would otherwise neutralize Cefuroxime, thereby broadening its effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Ceroxitum CV 500mg/125mg Tablet use.
PregnancySAFE IF PRESCRIBED
The use of Ceroxitum CV 500mg/125mg tablets during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Ceroxitum CV 500mg/125mg tablets pose minimal breastfeeding risk. Research in humans indicates negligible drug transfer to breast milk, presenting no apparent harm to infants.
DrivingNOT RELEVANT
Ceroxitum CV 500mg/125mg Tablets are restricted to inpatient use.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceroxitum CV 500mg/125mg tablets to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Data regarding Ceroxitum CV 500mg/125mg Tablet use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Ceroxitum CV 500mg/125mg Tablet :
Should you forget a Ceroxitum CV 500mg/125mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ceroxitum CV 500mg/125mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
